Department of Psychology, American University, Washington, DC, United States of America.
Department of Psychology, The Catholic University of America, Washington, DC, United States of America.
PLoS One. 2022 Feb 3;17(2):e0262592. doi: 10.1371/journal.pone.0262592. eCollection 2022.
Suicide rates have been steadily increasing in both the U.S. general population and military, with significant psychological and economic consequences. The purpose of the current study was to examine the economic costs and cost-benefit of the suicide-focused Collaborative Assessment and Management of Suicidality (CAMS) intervention versus enhanced treatment as usual (ETAU) in an active duty military sample using data from a recent randomized controlled trial of CAMS versus ETAU. The full intent-to-treat sample included 148 participants (mean age 26.8 years ± 5.9 SD years, 80% male, 53% White). Using a micro-costing approach, the cost of each condition was calculated at the individual level from a healthcare system perspective. Benefits were estimated at the individual level as cost savings in past-year healthcare expenditures based on direct care reimbursement rates. Cost-benefit was examined in the form of cost-benefit ratios and net benefit. Total costs, benefits, cost-benefit ratios, and net benefit were calculated and analyzed using general linear mixed modeling on multiply imputed datasets. Results indicated that treatment costs did not differ significantly between conditions; however, CAMS was found to produce significantly greater benefit in the form of decreased healthcare expenditures at 6-month follow-up. CAMS also demonstrated significantly greater cost-benefit ratios (i.e., benefit per dollar spent on treatment) and net-benefit (i.e., total benefit less the cost of treatment) at 12-month follow-up. The current study suggests that beyond its clinical effectiveness, CAMS may also convey potential economic advantages over usual care for the treatment of suicidal active duty service members. Our findings demonstrate cost savings in the form of reduced healthcare expenditures, which theoretically represent resources that can be reallocated toward other healthcare system needs, and thus lend support toward the overall value of CAMS.
自杀率在美国普通人群和军队中都在稳步上升,造成了重大的心理和经济后果。本研究的目的是利用最近一项关于 CAMS 与 ETAU 的随机对照试验的数据,检查针对自杀的协作评估和管理(CAMS)干预与增强的常规治疗(ETAU)相比在现役军事样本中的经济成本和成本效益。全意向治疗样本包括 148 名参与者(平均年龄 26.8 岁±5.9 岁标准差,80%男性,53%白人)。使用微观成本法,从医疗保健系统的角度在个人层面上计算每种情况的成本。效益是根据直接护理报销率,在个人层面上作为过去一年医疗保健支出的节省来估计的。从成本效益比和净效益的角度检查了成本效益。使用多重插补数据集的广义线性混合模型计算和分析了总成本、效益、成本效益比和净效益。结果表明,治疗成本在两种情况下没有显著差异;然而,在 6 个月的随访中,CAMS 被发现显著降低了医疗保健支出,从而产生了更大的效益。CAMS 在 12 个月的随访中还显示出更高的成本效益比(即每治疗花费一美元的效益)和净效益(即总效益减去治疗成本)。本研究表明,CAMS 除了具有临床疗效外,在治疗有自杀倾向的现役军人方面,还可能比常规护理具有潜在的经济优势。我们的研究结果表明,以减少医疗保健支出的形式节省了成本,从理论上讲,这些资源可以重新分配到其他医疗保健系统的需求中,因此支持了 CAMS 的总体价值。